Correction to “A Carrier-Free Nanomedicine Enables Apoptosis-Ferroptosis Synergistic Breast Cancer Therapy by Targeting Subcellular Organelles”

Jiaxin Zhu,Kexin Zhang,Yan Zhou,Ruyi Wang,Liangping Gong,Can Wang,Keke Zhong,Wenyuan Liu,Feng,Wei Qu
DOI: https://doi.org/10.1021/acsami.3c06803
IF: 9.5
2023-01-01
ACS Applied Materials & Interfaces
Abstract:ADVERTISEMENT RETURN TO ISSUEPREVAddition/CorrectionNEXTORIGINAL ARTICLEThis notice is a correctionCorrection to "A Carrier-Free Nanomedicine Enables Apoptosis-Ferroptosis Synergistic Breast Cancer Therapy by Targeting Subcellular Organelles"Jiaxin ZhuJiaxin ZhuDepartment of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, ChinaMore by Jiaxin Zhu, Kexin ZhangKexin ZhangDepartment of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, ChinaMore by Kexin Zhang, Ya ZhouYa ZhouDepartment of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, ChinaMore by Ya Zhou, Ruyi WangRuyi WangDepartment of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, ChinaMore by Ruyi Wang, LiangPing GongLiangPing GongDepartment of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, ChinaMore by LiangPing Gong, Can WangCan WangDepartment of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, ChinaMore by Can Wang, Keke ZhongKeke ZhongDepartment of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, ChinaMore by Keke Zhong, Wenyuan LiuWenyuan LiuDepartment of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing 211198, ChinaKey Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical Unrsity, Nanjingive 211198, ChinaMore by Wenyuan Liuhttps://orcid.org/0000-0002-2536-9416, Feng Feng*Feng FengNanjing Medical University, Nanjing 211198, ChinaDepartment of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, ChinaMore by Feng Feng, and Wei Qu*Wei QuDepartment of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, ChinaMore by Wei Quhttps://orcid.org/0000-0003-2075-9033Cite this: ACS Appl. Mater. Interfaces 2023, 15, 24, 29653Publication Date (Web):June 9, 2023Publication History Received21 May 2023Published online9 June 2023Published inissue 21 June 2023https://pubs.acs.org/doi/10.1021/acsami.3c06803https://doi.org/10.1021/acsami.3c06803correctionACS PublicationsCopyright © 2023 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views479Altmetric-Citations-LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (798 KB) Get e-Alertsclose Get e-Alerts
What problem does this paper attempt to address?